EGAIN CORP (EGAN) Fundamental Analysis & Valuation

NASDAQ:EGAN • US28225C8064

8.76 USD
-0.23 (-2.56%)
At close: Mar 13, 2026
8.7206 USD
-0.04 (-0.45%)
After Hours: 3/13/2026, 8:22:37 PM

This EGAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, EGAN scores 6 out of 10 in our fundamental rating. EGAN was compared to 277 industry peers in the Software industry. EGAN scores excellent on profitability, but there are some minor concerns on its financial health. EGAN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. EGAN Profitability Analysis

1.1 Basic Checks

  • EGAN had positive earnings in the past year.
  • In the past year EGAN had a positive cash flow from operations.
  • Of the past 5 years EGAN 4 years were profitable.
  • Each year in the past 5 years EGAN had a positive operating cash flow.
EGAN Yearly Net Income VS EBIT VS OCF VS FCFEGAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 24.59%, EGAN belongs to the top of the industry, outperforming 97.83% of the companies in the same industry.
  • EGAN's Return On Equity of 40.65% is amongst the best of the industry. EGAN outperforms 94.58% of its industry peers.
  • EGAN has a Return On Invested Capital of 6.94%. This is in the better half of the industry: EGAN outperforms 77.26% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EGAN is significantly below the industry average of 10.89%.
  • The last Return On Invested Capital (6.94%) for EGAN is above the 3 year average (4.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 24.59%
ROE 40.65%
ROIC 6.94%
ROA(3y)9.83%
ROA(5y)6.73%
ROE(3y)18.89%
ROE(5y)13.5%
ROIC(3y)4.38%
ROIC(5y)N/A
EGAN Yearly ROA, ROE, ROICEGAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100

1.3 Margins

  • With an excellent Profit Margin value of 39.77%, EGAN belongs to the best of the industry, outperforming 94.95% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EGAN has grown nicely.
  • EGAN has a Operating Margin of 8.99%. This is in the better half of the industry: EGAN outperforms 75.45% of its industry peers.
  • EGAN's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 72.36%, EGAN is in line with its industry, outperforming 57.76% of the companies in the same industry.
  • EGAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.99%
PM (TTM) 39.77%
GM 72.36%
OM growth 3YN/A
OM growth 5Y-13.22%
PM growth 3YN/A
PM growth 5Y29.76%
GM growth 3Y-1.47%
GM growth 5Y-0.25%
EGAN Yearly Profit, Operating, Gross MarginsEGAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

6

2. EGAN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EGAN is destroying value.
  • The number of shares outstanding for EGAN has been reduced compared to 1 year ago.
  • EGAN has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for EGAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EGAN Yearly Shares OutstandingEGAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
EGAN Yearly Total Debt VS Total AssetsEGAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • EGAN has an Altman-Z score of 1.01. This is a bad value and indicates that EGAN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.01, EGAN perfoms like the industry average, outperforming 40.43% of the companies in the same industry.
  • EGAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.01
ROIC/WACC0.63
WACC10.98%
EGAN Yearly LT Debt VS Equity VS FCFEGAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • EGAN has a Current Ratio of 1.90. This is a normal value and indicates that EGAN is financially healthy and should not expect problems in meeting its short term obligations.
  • EGAN has a Current ratio (1.90) which is in line with its industry peers.
  • EGAN has a Quick Ratio of 1.90. This is a normal value and indicates that EGAN is financially healthy and should not expect problems in meeting its short term obligations.
  • EGAN has a Quick ratio of 1.90. This is comparable to the rest of the industry: EGAN outperforms 57.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
EGAN Yearly Current Assets VS Current LiabilitesEGAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

5

3. EGAN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.67% over the past year.
  • Measured over the past years, EGAN shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.51% on average per year.
  • The Revenue has been growing slightly by 1.94% in the past year.
  • The Revenue has been growing slightly by 3.99% on average over the past years.
EPS 1Y (TTM)66.67%
EPS 3Y-11.65%
EPS 5Y-6.51%
EPS Q2Q%175%
Revenue 1Y (TTM)1.94%
Revenue growth 3Y-1.29%
Revenue growth 5Y3.99%
Sales Q2Q%2.64%

3.2 Future

  • EGAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.60% yearly.
  • Based on estimates for the next years, EGAN will show a small growth in Revenue. The Revenue will grow by 4.57% on average per year.
EPS Next Y81.9%
EPS Next 2Y38.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.86%
Revenue Next 2Y4.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EGAN Yearly Revenue VS EstimatesEGAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
EGAN Yearly EPS VS EstimatesEGAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

6

4. EGAN Valuation Analysis

4.1 Price/Earnings Ratio

  • EGAN is valuated rather expensively with a Price/Earnings ratio of 21.90.
  • Compared to the rest of the industry, the Price/Earnings ratio of EGAN indicates a somewhat cheap valuation: EGAN is cheaper than 65.70% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of EGAN to the average of the S&P500 Index (25.70), we can say EGAN is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 22.80, EGAN is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as EGAN.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. EGAN is around the same levels.
Industry RankSector Rank
PE 21.9
Fwd PE 22.8
EGAN Price Earnings VS Forward Price EarningsEGAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • EGAN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EGAN is cheaper than 76.90% of the companies in the same industry.
  • EGAN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EGAN is cheaper than 82.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.59
EV/EBITDA 19.2
EGAN Per share dataEGAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • EGAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of EGAN may justify a higher PE ratio.
  • EGAN's earnings are expected to grow with 38.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y38.6%
EPS Next 3YN/A

0

5. EGAN Dividend Analysis

5.1 Amount

  • No dividends for EGAN!.
Industry RankSector Rank
Dividend Yield 0%

EGAN Fundamentals: All Metrics, Ratios and Statistics

EGAIN CORP

NASDAQ:EGAN (3/13/2026, 8:22:37 PM)

After market: 8.7206 -0.04 (-0.45%)

8.76

-0.23 (-2.56%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-03
Earnings (Next)05-12
Inst Owners56.78%
Inst Owner Change4.04%
Ins Owners35.54%
Ins Owner Change0%
Market Cap239.94M
Revenue(TTM)90.73M
Net Income(TTM)36.09M
Analysts77.78
Price Target14.79 (68.84%)
Short Float %5.86%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.9%
Min EPS beat(2)47.07%
Max EPS beat(2)58.73%
EPS beat(4)3
Avg EPS beat(4)26.73%
Min EPS beat(4)-34.64%
Max EPS beat(4)58.73%
EPS beat(8)7
Avg EPS beat(8)140.21%
EPS beat(12)11
Avg EPS beat(12)126.23%
EPS beat(16)15
Avg EPS beat(16)244.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.74%
Max Revenue beat(2)0.25%
Revenue beat(4)1
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)0.25%
Revenue beat(8)2
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)6
Avg Revenue beat(16)-0.79%
PT rev (1m)-4.4%
PT rev (3m)-17.14%
EPS NQ rev (1m)55.56%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)8.08%
EPS NY rev (3m)3.38%
Revenue NQ rev (1m)0.81%
Revenue NQ rev (3m)-1.75%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 21.9
Fwd PE 22.8
P/S 2.64
P/FCF 13.59
P/OCF 13.02
P/B 2.7
P/tB 3.17
EV/EBITDA 19.2
EPS(TTM)0.4
EY4.57%
EPS(NY)0.38
Fwd EY4.39%
FCF(TTM)0.64
FCFY7.36%
OCF(TTM)0.67
OCFY7.68%
SpS3.31
BVpS3.24
TBVpS2.76
PEG (NY)0.27
PEG (5Y)N/A
Graham Number5.4
Profitability
Industry RankSector Rank
ROA 24.59%
ROE 40.65%
ROCE 8.67%
ROIC 6.94%
ROICexc 59.75%
ROICexgc N/A
OM 8.99%
PM (TTM) 39.77%
GM 72.36%
FCFM 19.45%
ROA(3y)9.83%
ROA(5y)6.73%
ROE(3y)18.89%
ROE(5y)13.5%
ROIC(3y)4.38%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.47%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-13.22%
PM growth 3YN/A
PM growth 5Y29.76%
GM growth 3Y-1.47%
GM growth 5Y-0.25%
F-Score7
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 222.7%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 216.74%
Profit Quality 48.91%
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 1.01
F-Score7
WACC10.98%
ROIC/WACC0.63
Cap/Depr(3y)92.17%
Cap/Depr(5y)98.95%
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.47%
Profit Quality(3y)125.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3Y-11.65%
EPS 5Y-6.51%
EPS Q2Q%175%
EPS Next Y81.9%
EPS Next 2Y38.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.94%
Revenue growth 3Y-1.29%
Revenue growth 5Y3.99%
Sales Q2Q%2.64%
Revenue Next Year3.86%
Revenue Next 2Y4.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y147.89%
EBIT growth 3YN/A
EBIT growth 5Y-9.76%
EBIT Next Year126.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.5%
FCF growth 3Y-14.4%
FCF growth 5Y-19.09%
OCF growth 1Y50.21%
OCF growth 3Y-13.46%
OCF growth 5Y-17.84%

EGAIN CORP / EGAN FAQ

What is the ChartMill fundamental rating of EGAIN CORP (EGAN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EGAN.


What is the valuation status for EGAN stock?

ChartMill assigns a valuation rating of 6 / 10 to EGAIN CORP (EGAN). This can be considered as Fairly Valued.


What is the profitability of EGAN stock?

EGAIN CORP (EGAN) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EGAIN CORP (EGAN) stock?

The Price/Earnings (PE) ratio for EGAIN CORP (EGAN) is 21.9 and the Price/Book (PB) ratio is 2.7.


Can you provide the financial health for EGAN stock?

The financial health rating of EGAIN CORP (EGAN) is 6 / 10.